Payel Chatterjee - Related publications

NCBS, Bangalore, India, Bengaluru, Karnataka, India 
Insect flight
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
31 most relevant papers in past 60 days:
Year Citation  Score
2022 Bouyahya A, El Allam A, Zeouk I, Taha D, Zengin G, Goh BH, Catauro M, Montesano D, El Omari N. Pharmacological Effects of Grifolin: Focusing on Anticancer Mechanisms. Molecules (Basel, Switzerland). 27. PMID 35011516 DOI: 10.3390/molecules27010284   
2022 Khalafi S, Zhu S, Khurana R, Lohse I, Giordano S, Corso S, Al-Ali H, Brothers SP, Wahlestedt C, Schürer S, El-Rifai W. A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer. Translational Oncology. 15: 101260. PMID 34735897 DOI: 10.1016/j.tranon.2021.101260   
2022 Pan G, Zhang K, Geng S, Lan C, Hu X, Li C, Ji H, Li C, Hu X, Wang Y, Lv M, Cui H. PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer. Cancer Letters. PMID 35074497 DOI: 10.1016/j.canlet.2022.01.002   
2022 Sun Z, Zhang Z, Wang QQ, Liu JL. Combined inactivation of CTPS1 and ATR is synthetically lethal to MYC-overexpressing cancer cells. Cancer Research. PMID 35022212 DOI: 10.1158/0008-5472.CAN-21-1707   
2022 Qian J, Huang C, Zhu Z, He Y, Wang Y, Feng N, He S, Li X, Zhou L, Zhang C, Gong Y. NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer. Carcinogenesis. PMID 35022660 DOI: 10.1093/carcin/bgac006   
2022 Salvi A, Young AN, Huntsman AC, Pergande MR, Korkmaz MA, Rathnayake RA, Mize BK, Kinghorn AD, Zhang X, Ratia K, Schirle M, Thomas JR, Brittain SM, Shelton C, Aldrich LN, et al. PHY34 inhibits autophagy through V-ATPase V0A2 subunit inhibition and CAS/CSE1L nuclear cargo trafficking in high grade serous ovarian cancer. Cell Death & Disease. 13: 45. PMID 35013112 DOI: 10.1038/s41419-021-04495-w   
2022 Alqahtani AS, Ghorab MM, Nasr FA, Ahmed MZ, Al-Mishari AA, Attia SM. Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 37: 86-99. PMID 34894963 DOI: 10.1080/14756366.2021.1983807   
2022 Lee HJ, Min HY, Yong YS, Ann J, Nguyen CT, La MT, Hyun SY, Le HT, Kim H, Kwon H, Nam G, Park HJ, Lee J, Lee HY. A novel C-terminal heat shock protein 90 inhibitor that overcomes STAT3-Wnt-β-catenin signaling-mediated drug resistance and adverse effects. Theranostics. 12: 105-125. PMID 34987637 DOI: 10.7150/thno.63788   
2022 Wilson Z, Odedra R, Wallez Y, Wijnhoven PWG, Hughes AM, Gerrard J, Jones GN, Bargh-Dawson H, Brown E, Young LA, O'Connor MJ, Lau A. ATR inhibitor AZD6738 (ceralasertib) exerts antitumor activity as a monotherapy and in combination with chemotherapy and the PARP inhibitor olaparib. Cancer Research. PMID 35078817 DOI: 10.1158/0008-5472.CAN-21-2997   
2022 Acar Çevik U, Celik I, Işık A, Ahmad I, Patel H, Özkay Y, Kaplancıklı ZA. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors. Journal of Biomolecular Structure & Dynamics. 1-15. PMID 35037830 DOI: 10.1080/07391102.2022.2025906   
2022 Gu YQ, Shen WY, Yang QY, Chen ZF, Liang H. Ru(III) complexes with pyrazolopyrimidines as anticancer agents: bioactivities and the underlying mechanisms. Dalton Transactions (Cambridge, England : 2003). PMID 34989734 DOI: 10.1039/d1dt02765d   
2022 Xiao Y, Yang K, Liu P, Ma D, Lei P, Liu Q. Deoxyribonuclease 1-like 3 Inhibits Hepatocellular Carcinoma Progression by Inducing Apoptosis and Reprogramming Glucose Metabolism. International Journal of Biological Sciences. 18: 82-95. PMID 34975319 DOI: 10.7150/ijbs.57919   
2022 Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, Gong K, Liu F, Duan Y, Li H. Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer. Journal of Nanobiotechnology. 20: 50. PMID 35078498 DOI: 10.1186/s12951-022-01264-5   
2022 Lim SM, Kim CG, Cho BC. Antibody-Drug Conjugates: A New Addition to the Treatment Landscape of EGFR-Mutant Non-Small Cell Lung Cancer. Cancer Research. 82: 18-20. PMID 34983785 DOI: 10.1158/0008-5472.CAN-21-3481   
2022 Ren K, Peng Q, Ding G, Yu Y, Huang T, Gong L, Yu T, Yang L. Potential biomarkers and resistance mechanisms of atezolizumab in a patient with lung squamous cell carcinoma. Immunotherapy. 14: 15-21. PMID 34763535 DOI: 10.2217/imt-2020-0325   
2022 Passaro A, Brahmer J, Antonia S, Mok T, Peters S. Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel Strategies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101845. PMID 34985992 DOI: 10.1200/JCO.21.01845   
2022 Guo T, Zhang Z, Zhu L, Chen W, Ding Y, Li W, Huang Y, Huang J, Pan X. TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail1. Cancer Biology & Therapy. 1-10. PMID 34974792 DOI: 10.1080/15384047.2021.2004835   
2022 Song G, Shang C, Sun L, Li Y, Zhu Y, Xiu Z, Liu Z, Li Y, Yang X, Ge C, Fang J, Jin N, Li X. Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo. Investigational New Drugs. PMID 34981275 DOI: 10.1007/s10637-021-01204-4   
2022 Chitti S, Pulya S, Nandikolla A, Patel TK, Banoth KK, Murugesan S, Ghosh B, Chandra Sekhar Kondapalli VG. Design, synthesis and structure-activity relationship studies of novel spirochromanone hydrochloride analogs as anticancer agents. Future Medicinal Chemistry. PMID 34985322 DOI: 10.4155/fmc-2021-0237   
2022 Elmaaty AA, Darwish KM, Chrouda A, Boseila AA, Tantawy MA, Elhady SS, Shaik AB, Mustafa M, Al-Karmalawy AA. In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity. Acs Omega. 7: 875-899. PMID 35036753 DOI: 10.1021/acsomega.1c05519   
2022 Zhang Z, Qin S, Chen Y, Zhou L, Yang M, Tang Y, Zuo J, Zhang J, Mizokami A, Nice EC, Chen HN, Huang C, Wei X. Inhibition of NPC1L1 disrupts adaptive responses of drug-tolerant persister cells to chemotherapy. Embo Molecular Medicine. e14903. PMID 35023619 DOI: 10.15252/emmm.202114903   
2022 Pilut CN, Manea A, Macasoi I, Dobrescu A, Georgescu D, Buzatu R, Faur A, Dinu S, Chioran D, Pinzaru I, Hancianu M, Dehelean C, Malița D. Comparative Evaluation of the Potential Antitumor of in Skin and Breast Cancer. Plants (Basel, Switzerland). 11. PMID 35050083 DOI: 10.3390/plants11020194   
2022 Raj S, Jayaraj R, Kodiveri Muthukaliannan G. Chemical Profiling and Evaluation of Antioxidant and Anticancer Potential of Tuber Crop Amorphophallus commutatus var. wayanadensis. Plant Foods For Human Nutrition (Dordrecht, Netherlands). PMID 34977995 DOI: 10.1007/s11130-021-00942-3   
2022 Jung JY, Koh SA, Lee KH, Kim JR. 14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion Matrix Metalloproteinase-1 Regulation in Human Gastric Cancer. Anticancer Research. 42: 519-530. PMID 34969762 DOI: 10.21873/anticanres.15510   
2022 Feng J, Li S, Zhang B, Duan N, Zhou R, Yan S, Elango J, Liu N, Wu W. FGFC1 Exhibits Anti-Cancer Activity via Inhibiting NF-κB Signaling Pathway in -Mutant NSCLC Cells. Marine Drugs. 20. PMID 35049931 DOI: 10.3390/md20010076   
2022 Yang KS, Che PC, Hsieh MJ, Lee IN, Wu YP, Chen MS, Chen JC. Propofol induces apoptosis and ameliorates 5‑fluorouracil resistance in OSCC cells by reducing the expression and secretion of amphiregulin. Molecular Medicine Reports. 25. PMID 34859260 DOI: 10.3892/mmr.2021.12552   
2022 Pink RC, Beaman EM, Samuel P, Brooks SA, Carter DRF. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future. British Journal of Cancer. PMID 35013578 DOI: 10.1038/s41416-021-01668-4   
2022 Feng Y, Lu Y, Li J, Zhang H, Li Z, Feng H, Deng X, Liu D, Shi T, Jiang W, He Y, Zhang J, Wang Z. Design, synthesis and biological evaluation of novel o-aminobenzamide derivatives as potential anti-gastric cancer agents in vitro and in vivo. European Journal of Medicinal Chemistry. 227: 113888. PMID 34628244 DOI: 10.1016/j.ejmech.2021.113888   
2022 Gao W, Zhang S, Guorong L, Liu Q, Zhu A, Gui F, Zou Y, Wu Y, Luo Y, Hong Z. Nc886 promotes renal cancer cell drug-resistance by enhancing EMT through Rock2 phosphorylation-mediated β-catenin nuclear translocation. Cell Cycle (Georgetown, Tex.). 1-12. PMID 34974812 DOI: 10.1080/15384101.2021.2020431   
2022 Granade ME, Manigat LC, Lemke MC, Purow BW, Harris TE. Identification of ritanserin analogs that display DGK isoform specificity. Biochemical Pharmacology. 197: 114908. PMID 34999054 DOI: 10.1016/j.bcp.2022.114908   
2022 Song JW, Suh J, Lee SW, Yoo JK, Lee U, Han JH, Kwak C, Kang M, Kim YR, Jeong CW, Choi JW. Isolation and Genomic Analysis of Single Circulating Tumor Cell Using Human Telomerase Reverse Transcriptase and Desmoglein-2. Small Methods. e2100938. PMID 35038250 DOI: 10.1002/smtd.202100938